What is the Nephrology Lasers Market Size?
The global nephrology lasers market size accounted for USD 9.02 billion in 2025 and is predicted to increase from USD 10.05 billion in 2026 to approximately USD 26.67 billion by 2035, expanding at a CAGR of 11.45% from 2026 to 2035. The nephrology lasers market is skyrocketing due to the rise in incidence of kidney-related disorders and urological conditions, the surge in minimally invasive surgical procedures, and advancements in laser technology.
Market Highlights
- North America dominated the market, holding a share of approximately 38% in 2025.
- Asia-Pacific is expected to expand with the highest CAGR of approximately 11.6% during the forecast period.
- By laser type, the holmium lasers segment held the largest nephrology lasers market share of approximately 41% in 2025.
- By laser type, the thulium lasers segment is expected to grow at a remarkable CAGR between 2026 and 2035.
- By application, the kidney stone management segment held a major market share of approximately 49% in 2025.
- By application, the soft tissue ablation segment is expected to be the fastest-growing segment during the forecast period.
- By end user, the hospitals and specialty clinics segment dominated the market with a share of approximately 56% in 2025.
- By end user, the ambulatory surgical centers segment is expected to grow at the highest CAGR between 2026 and 2035.
- By technology platform, the lithotripsy-focused systems segment led the nephrology lasers market with a share of approximately 44% in 2025.
- By technology platform, the soft tissue laser platforms segment is expected to show the fastest growth in the forecast period.
- By procedure type, the percutaneous nephrolithotomy (PCNL) segment contributed the biggest market share of approximately 38% in 2025.
- By procedure type, the ureteroscopy procedures segment is expected to grow swiftly between 2026 and 2035.
What is the Landscape of the Nephrology Lasers Market?
The market centers on innovation, implementation, and application of minimally invasive laser technologies for treating kidney-related conditions and urological diseases. This is experiencing rapid growth due to a surge in the aging population, a rise in kidney diseases, especially kidney stones, a rise in demand for non-invasive techniques that provide faster recovery and minimal pain, and innovation within the field of lasers. The market is significantly expanding due to innovations in robot-assisted surgeries, and complex hemodialysis access management is further boosting the market.
What is the Function of AI in the Nephrology Lasers Market?
Artificial intelligence is transforming the market by improving diagnostic precision, enhancing treatment, enabling predictive analytics, personalizing, optimizing healthcare workflow, and improving patient satisfaction for various procedures. By analyzing digital pathology images and data, AI-driven lasers are enhancing clinical decision-making, leading to more customized, effective, and minimally invasive kidney care.
Treatment techniques like laser lithotripsy are gaining popularity in the market due to reduced recovery time. The integration of AI aims to improve the decision-making of nephrologists so as to improve efficiency and personalized care. Despite all its potential, it still faces major challenges regarding data privacy and stringent regulatory standards.
Nephrology Lasers Market Trends
- Minimally Invasive Procedures: These procedures are gaining huge traction due to their ability to provide superior patient outcomes, such as reduced recovery time, minimal pain, fewer complications, and better cosmetic results.
- Developments in Fiber Laser Technology: The market is pivoting towards fiber laser technology as it provides higher precision in treating kidney stones, efficiency in treating urological conditions, reduced procedure time, and a better safety profile.
- Technological Integration: The integration of AI and robotic systems is shifting the market from traditional methods to advanced laser systems. There is a need for effective, faster, and non-invasive treatment to address nephrological and urological conditions.
- Dominance of Holmium Lasers: It is expanding rapidly in the market as it has become a gold standard for lithotripsy, and its superior ability to manage both hard stones and soft tissues.
Market Scope
| Report Coverage | Details |
| Market Size in 2025 | USD 9.02 Billion |
| Market Size in 2026 | USD 10.05 Billion |
| Market Size by 2035 | USD 26.67 Billion |
| Market Growth Rate from 2026 to 2035 | CAGR of 11.45% |
| Dominating Region | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Segments Covered | Laser Type, Application, End-User, Technology Platform, Procedure Type, and Region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Segmental Insights
Laser Type Insights
How the Holmium Lasers Segment Dominated the Nephrology Lasers Market?
The holmium laser segment dominated the market with a share of approximately 42% in 2025 due to its superior efficiency and high safety profile and provides dual action capabilities for both lithotripsy and soft tissue ablation. They are gold standard technology when coupled with MOSES technology, which ensures high clinical adoption. Holmium lasers are highly versatile, and they can also be used in ureteral strictures, providing a multi-purpose tool for surgeons, boosting the segment's growth.
The thulium lasers segment is expected to grow at the fastest CAGR in the market between 2026 and 2035 due to their superior performance, higher water absorption, and reduced retropulsion. There is increased traction for thulium lasers in ambulatory surgical centers due to their compact, quiet, energy-efficient, and air-cooled design. Their increased adoption of minimally invasive procedures is further expanding their market.
Application Insights
Which Application Segment Dominated the Nephrology Lasers Market?
The kidney stone management segment held the largest market share of approximately 49% in 2025 due to the surge in the prevalence of kidney stones, the rise in demand for minimally invasive procedures, and the clinical superiority of modern laser applications. The increasing adoption of outpatient care for kidney stones is propelling the demand for advanced laser systems in non-hospital settings. The innovation in laser technology makes kidney stone management a leader in this market.
The soft tissue ablation segment is expected to witness the fastest growth between 2026 and 2035, driven by the rise in demand for minimally invasive techniques and nephron-sparing procedures. The market is shifting from conventional surgeries toward quicker, more precise laser treatment, especially for small renal masses and benign prostatic hyperplasia. The increase in the prevalence of cancer is boosting the demand for targeted treatment.
End User Insights
What Made the Hospitals and Specialty Clinics Segment Lead the Nephrology Lasers Market?
The hospitals and specialty clinics segment led the market with a share of approximately 56% in 2025 due to its well-established infrastructure, ability to handle high-density patients, and presence of skilled professionals to perform complicated and minimally invasive procedures. The expansion is supported by a rise in investment in hospital infrastructure to manage the rise in incidence of kidney diseases. By offering comprehensive care, such as advanced laser systems for various kidney or urological conditions, they facilitate their market leadership.
The ambulatory surgical centers segment is expected to rise with the highest CAGR in the forecasted period, as they are cost-effective, efficient, and patient-friendly compared to traditional hospitals. The market is driven by a surge in demand for outpatient kidney stone management, favorable reimbursement policies, and technological advancements, which allow procedures to be done in a single day, augmenting the segment's growth.
Technology Platform Insights
How the Lithotripsy-Focused Systems Segment Dominated the Nephrology Lasers Market?
The lithotripsy-focused systems segment held a dominant market share of approximately 44% in 2025, as they deliver highly effective, minimally invasive, versatile solutions to tackle the rapidly rising prevalence of kidney stones. This system offers a high success rate with minimal tissue damage and fewer complications. This market is further driven by innovation in laser technology and increasing adoption in hospitals.
The soft tissue laser platforms segment is expected to grow at the highest CAGR over the studied period, driven by superior performance in soft tissue handling, high accuracy in stone dusting, and superior patient outcomes. It provides a safer, faster, and more effective dusting technique, which reduces the repetition of the procedure and the number of complications.
Procedure Type Insights
Why Did the Percutaneous Nephrolithotomy Segment Hold the Largest Share of the Nephrology Lasers Market?
The percutaneous nephrolithotomy held the largest share of approximately 38% in the market in 2025. This procedure segment is a gold standard for treating large, complex, or staghorn kidney stones. The segmental growth is attributed to its superior single-session stone-free rate. Its integration with advanced technology allows for efficient and faster fragmentation compared to other procedures. PCNL is the preferred choice for this disease, as it results in less post-op pain, shorter hospital stays, and quicker recovery.
The ureteroscopy procedures segment is expected to grow with the highest CAGR during the forecast period, driven by superior clinical outcomes, advanced technology, a surge in the incidence of urological diseases, a pivot towards single-use ureteroscopes, and growing healthcare infrastructure. The market is shifting from fiber optic systems to digital, high-definition, flexible ureteroscopes, fostering the segment's growth.
Regional Insights
How Big is the North America Nephrology Lasers Market Size?
The North America nephrology lasers market size is estimated at USD 3.43 billion in 2025 and is projected to reach approximately USD 10.27 billion by 2035, with a 11.59% CAGR from 2026 to 2035.
What factors Drive North America's Leadership in the Nephrology Lasers Market?
North America dominated the market with a share of approximately 38% in 2025. Its dominance is due to a surge in kidney disease prevalence, a well-established healthcare ecosystem, and rapid adoption of minimally invasive procedures. The market is driven by massive RandD investments, favorable reimbursement policies, and the presence of major companies. The various RandD and government initiatives like Thulium Fiber Lasers, Steerable Ureteroscopic Renal Stone Evacuation (SURE), and Advancing American Kidney Health are further boosting this market. This market is further expanded by the aging population and the rise in the incidence of diabetes, which leads to kidney-related issues.
What is the Size of the U.S. Nephrology Lasers Market?
The U.S. nephrology lasers market size is calculated at USD 2.57 billion in 2025 and is expected to reach nearly USD 7.75 billion in 2035, accelerating at a strong CAGR of 11.67% between 2026 and 2035.
U.S. Market Trends
The U.S. dominates the North American market due to an advanced healthcare ecosystem, a rise in the incidence of kidney-related issues, cutting-edge technologies, and rapid adoption of minimally invasive procedures. Massive healthcare investments, favorable reimbursement policies, and robust RandD infrastructure drive this market leadership. Government organizations provide funding for adopting advanced devices in healthcare settings.
Why is Asia-Pacific Growing in the Nephrology Lasers Market?
Asia-Pacific is expected to grow with the highest CAGR of approximately 11.6% during the forecast period. This region is experiencing massive growth due to a surge in the incidence of kidney diseases, rapid technological adoption, a rise in healthcare expenditure, and a strong preference for minimally invasive techniques. RandD and technological advancements like robotic-assisted laser surgeries and the Olympus Asia Pacific Innovation Program (OAIP) are further expanding this market.
China Market Trends
China leads this market in the Asia-Pacific region due to its aging population and rise in incidence of chronic kidney disease and stones, paired with rapid, high-volume adoption of laser surgeries. Robust government healthcare initiatives and a surge in investment in medical infrastructure drive the demand for advanced lasers. China is the largest regional market due to its high manufacturing capabilities and increased healthcare spending.
Which Region Shows Significant Growth in the Nephrology Lasers Market?
Europe is expected to grow at a significant CAGR in the market during the predicted timeframe due to its aging population, the surge in prevalence of kidney stones and chronic kidney disease (CKD), and a strong pivot toward minimally invasive, outpatient procedures. The market is supported by cutting-edge laser technology and high healthcare investment. The rapid growth of Ambulatory Surgical Centers (ASCs) and specialized clinics in Europe has further boosted this market.
Germany Market Trends
Germany leads this position due to its advanced healthcare infrastructure, surge in aging population, strong manufacturing base, and presence of major companies. The market is driven by high expenditure in healthcare, significant RandD investments, and strict regulatory standards. Germany's precise, superior standard, and compliant manufacturing sector aligns with these regulations, solidifying its position in the market.
Nephrology Lasers Market Value Chain Analysis
Who are the Major Players in the Global Nephrology Lasers Market?
The major players in the nephrology lasers market include Boston Scientific Corporation (BSC), Lumenis Be Ltd, Quanta System S.p.A., Cook Group Incorporated (Cook Medical), Richard Wolf GmbH, Olympus Corporation, Convergent Laser Technologies, Dornier MedTech GmbH, Biolitec AG, Hyper Photonics S.R.L, Asclepion Laser Technologies GmbH, Medtronic plc, Potent Medical, AMS Group (American Medical Systems), and Alma Lasers.
Recent Developments
- In October 2025, Avvio Medical announced that it received an FDA approval for its Avvio Enhanced Lithotripsy System. It is a minimally invasive treatment for ureteral stones that is safe and efficient. (Source: https://www.urologytimes.com)
- In September 2025, Mendaera announced that the first procedures using the Focalist handheld robotic system had been successfully performed. This device received its FDA clearance in July 2025 and is expected to launch in 2026. (Source: https://www.urologytimes.com)
Segments Covered in the Report
By Laser Type
- Holmium Lasers
- Pulsed holmium:YAG lasers
- High-energy lithotripsy systems
- Thulium Lasers
- Continuous wave thulium systems
- Soft tissue ablation optimized
- Diode Lasers
- Compact diode units
- Fiber-delivered diode systems
- Other Lasers
- Nd:YAG lasers
- Emerging laser technologies
By Application
- Kidney Stone Management
- Lithotripsy procedures
- PCNL and ureteroscopy
- Soft Tissue Ablation
- Renal Biopsy and Diagnostics
- Hemostasis and Tissue Coagulation
- Other Applications
By End-User
- Hospitals and Specialty Clinics
- Ambulatory Surgical Centers (ASCs)
- Diagnostic Centers
- Other End Users
By Technology Platform
- Lithotripsy-Focused Systems
- High-power lithotripters
- Integrated stone removal platforms
- Soft Tissue Laser Platforms
- Tissue vaporization optimized
- Multipurpose Nephrology Lasers
- Dual-mode or hybrid systems
By Procedure Type
- Percutaneous Nephrolithotomy (PCNL)
- Ureteroscopy Procedures
- Extracorporeal Shock Wave Lithotripsy (ESWL)
- Other Procedures
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
Frequently Asked Questions
Tags
Ask For Sample
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Table Of Content
sales@precedenceresearch.com
+1 804-441-9344
Schedule a Meeting